Various mutations in human DYNC1H1 have been associated with neurological diseases, including spinal muscular atrophy, Charcot–Marie–Tooth disease, and infantile developmental and epileptic encephalopathy (Hoang et al., 2017; Marzo et al., 2019; Su et al., 2022). Here, DYNC1H1 is linked to nervous system disorder.